Playback speed
10 seconds
AHA 2020 Trial Takeaways: Should Rivaroxaban Be Used in Patients with Bioprosthetic Valves? Can Vitamin D, Omega-3 Supplementation and Early Ablation Decrease the Incidence of Afib and Other CV Events?
By
The North American Thrombosis Forum (NATF)
FEATURING
Christian Ruff
By
The North American Thrombosis Forum (NATF)
FEATURING
Christian Ruff
624 views
December 17, 2020
Comments 1
Login to view comments.
Click here to Login